India is a diverse land where various religions and communities celebrate numerous festivals. This season is when the demand for products and services is high, resulting in extra expenses and an issue of inadequate funds. And as we step into the festive season, the demand for short term loans are seeing a sharp spike. But should you really opt for short term loans this festive season? How should you budget for your expenses?  And what are the factors that you must keep in mind before taking a short term loan to fund your festive spends. On The Money Show, we brought on board Satyam Kumar, CEO & Co- Founder, LoanTap. Listen in.

ETF is a type of mutual fund scheme that is listed and traded on the stock exchange and can be bought and sold through the exchange just like stocks. The majority of exchange-traded funds are passively managed while there are actively managed ETFs as well. Passive ETFs can be structured to track anything like an index such as NIFTY 50, which will invest in the companies of Nifty 50 in the same proportion. They may also track an index representing a sector (like NIFTY Pharma), or a commodity, like gold, which tracks the physical gold price. On The Money Show, we brought on board Suresh Sadagopan, Founder, Ladder7 Financial Advisories to learn more about ETFs. Listen in.

There are plethora of funds available in the market to invest your hard-earned money in. But like one-size shoes cannot fit all, one style of mutual fund will not meet your return expectation and every one's risk-taking ability. So now the big question is: How do you assess which is the right fund for your portfolio? What are the criteria that one should look at? To help you navigate through this maze, on the ET Money Show, we brought on board Aditya Shah, Founder, Hercules Advisors. Also, do not forget to send us your portfolio queries on our WhatsApp number - 865 - 797 - 4571  or Email Us Queries On themoneyshow@etnow.tv

#shorttermloans #festiveseason #extraexpenses #satyamkumar #loantrip #etnowshow #themoneyshow
Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | ► https://goo.gl/SEjvK3

Subscribe Now To Our Network Channels :-
Times Now  : http://goo.gl/U9ibPb
The NewsHour Debate : http://goo.gl/LfNgFF

To Stay Updated Download the Times Now App :-
Android Google Play :  https://goo.gl/zJhWjC
Apple App Store :  https://goo.gl/d7QBQZ

Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC
G+ - http://goo.gl/hYxrmj
Website - www.etnownews.com

Factors To Keep In Mind Before Taking Short-Term Loan | All You Need To Know About ETFs | ET Now

S&P revised its outlook to ‘positive’ from ‘stable’ as the stake sale in its lifescience unit will strengthen its financials

Glenmark Pharma Shares Surge 10% On S&P Rating Outlook Upgrade

Sun Pharma and Cipla better poised to mitigate the Revlimid cliff.

Pharma Sector Check - Can Indian Generic Players Mitigate The Revlimid Cliff? Systematix

The S&P BSE Sensex closed up 173 points, or 0.26%, at 66,118.69 while the NSE Nifty 50 was 52 points or 0.26% lower at 19,716.45.

Stock Market Today: Sensex, Nifty Close Higher As RIL, ITC Lead; Pharma Stocks Rise

This was a Pre-Approval Inspection (PAI) 7 products and Good Manufacturing Practice (GMP).

Gland Pharma shares recover after EIR from USFDA for Hyderabad facility

The workshops use a presentation, accessed by News18, which starts with the basic concept of the need for good manufacturing practices and list several reasons such as avoiding mix-ups, contamination, and producing consistent quality

From Fixing Drug Recalls to New Work Structures, Govt Coaches Pharma Industry on Revised Drug Laws - News18

The pharma company will sell a 75% stake in Glenmark Life Sciences at Rs 615 apiece, lowering the stake to 7.84% after the sale.

Glenmark Pharma Shares Fall As It Plans To Sell Life Sciences Business

What’s In Store For Diagnostic & Pharma Stocks

#Thyrocare's Rahul Guha talks about the surge in diagnostic stocks and what's next for the #pharma sector. #bqlive 
---------------------------------------------------------------------------------------------------------------------------------------------------
For more videos subscribe to our channel: http://bit.ly/32JXa74
Visit BQ Prime for more news: https://www.bqprime.com/
Don't enter the stock market unaware. Read all Research Reports here: https://www.bqprime.com/research-reports

For the latest business news and analysis
Subscribe to our Newsletters here: https://www.bqprime.com/my-bq/newsletter
Subscribe to our Telegram channel: https://t.me/BQPrime

Follow BQ Prime here
Twitter: https://twitter.com/bqprime
Facebook: https://www.facebook.com/BQPrime/
LinkedIn: https://www.linkedin.com/company/1318...
Instagram: https://www.instagram.com/bqprime/
Pinterest: https://in.pinterest.com/BQPrimeNews/

What's In Store For Diagnostic & Pharma Stocks? | BQ Prime

Pharmaceutical company Strides Pharma Science shares rose over 11.5% to hit a 52-week high; Details

Strides Pharma Shares Hit 52-Week High As USFDA Tentative Nod To HIV Treatment Drug - News18

Ajanta Pharma “outperformed” the market, led by ophthalmology therapy, pain therapy, and dermatology, the brokerage said.

Ajanta Pharma Shares At All-Time High After August Sales Data

Nifty Pharma Index is designed to reflect the behavior and performance of the pharmaceutical sector in India. The rescheduling of index constituents happens bi-annually every year.